Mizuho Trust & Banking’s Ionis Pharmaceuticals IONS Stock Holding History

Mizuho Trust & Banking’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-185,348	Closed	-$4.32M	–	848
2016 Q2	$4.32M	Sell	185,348 -6,441	-3%	-$208K	0.01%	642
2016 Q1	$7.77M	Buy	191,789 +20,542	+12%	+$834K	0.02%	579
2015 Q4	$10.5M	Buy	171,247 +781	+0.5%	+$42.1K	0.03%	511
2015 Q3	$6.89M	Buy	170,466 +1,439	+0.9%	+$74.5K	0.02%	588
2015 Q2	$9.73M	Buy	169,027 +10,314	+6%	+$656K	0.03%	552
2015 Q1	$10.1M	Buy	+158,713	New	+$10.8M	0.03%	541

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mizuho Trust & Banking's IONS Position: Q3 2016 in Review

Mizuho Trust & Banking sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 185,348 shares — an estimated $4.32M sold.

Mizuho Trust & Banking first reported a position in IONS in Q1 2015 and held it in 6 quarters. The position peaked at $10.5M in Q4 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Mizuho Trust & Banking reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Mizuho Trust & Banking sold 185,348 Ionis Pharmaceuticals shares in Q3 2016, an estimated $4.32M.
Mizuho Trust & Banking first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Mizuho Trust & Banking's Ionis Pharmaceuticals position peaked at $10.5M in Q4 2015.
281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Mizuho Trust & Banking's 13F filing for Q3 2016, filed 1 Nov 2016.